Physician profile
David B Akers
NPI 1720308083
$1,631.48
in general payments reported to CMS, 2019-2025
26 companies · $218 in 2025
The $218 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2021: $261 · 2022: $168 · 2023: $247 · 2024: $575 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $472.36 | 2024-2025 | Qelbree |
| Dexcom, INC. | $167.81 | 2021-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $126.98 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Biohaven Pharmaceuticals, INC. | $111.22 | 2021 | |
| Grifols USA, LLC | $80.74 | 2023-2024 | Xembify, Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $71.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $66.56 | 2024-2025 | Dupixent |
| Novo Nordisk INC | $55.85 | 2021-2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $52.69 | 2022 | |
| Daiichi Sankyo INC. | $38.25 | 2022 | |
| Sobi, INC | $37.77 | 2019-2023 | |
| Philips North America LLC | $37.64 | 2022-2025 | Vest Therapy Und |
| Collegium Pharmaceutical, INC. | $35.60 | 2025 | Jornay Pm |
| Bayer Healthcare Pharmaceuticals INC. | $32.51 | 2019 | |
| Biomarin Pharmaceutical INC. | $29.83 | 2023 | Voxzogo 1.2mg |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $29.26 | 2025 | |
| Roche Diagnostics Corporation | $24.94 | 2019 | |
| Inspire Medical Systems, INC. | $24.07 | 2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $22.43 | 2023 | Acthar |
| Pfizer INC. | $20.03 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.54 | 2024 | Caplyta |
| Procept Biorobotics Corporation | $16.96 | 2023 | Aquabeam Robotic System |
| Amarin Pharma, INC. | $16.10 | 2021 | |
| Janssen Biotech, INC. | $15.65 | 2024 | Tremfya |
| Ironshore Pharmaceuticals INC. | $14.10 | 2023 | Jornay Pm |
| Phadia US INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Akers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.